您当前的位置：
首页 >
文章列表页 >
Gelian Tiaotang Pills Ameliorate Renal Fibrosis in db/db Mice via NLRP3/Caspase-1/GSDMD Pathway
更新时间：2025-03-04
|

    • Gelian Tiaotang Pills Ameliorate Renal Fibrosis in db/db Mice via NLRP3/Caspase-1/GSDMD Pathway

    • “Geliantiao Sugar Pill can interfere with renal fibrosis in type 2 diabetes through NLRP3/Caspase-1/GSDMD signaling pathway, effectively reduce inflammatory reaction and delay the process of disease.”
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 31, Issue 6, Pages: 136-145(2025)

    • DOI：10.13422/j.cnki.syfjx.20241319    

      CLC： R285;R289;R587.1

    • Received：08 July 2024，

      Accepted：2024-11-07，

      Published Online：05 September 2024，

      Published：20 March 2025

    移动端阅览

  • FAN Lihui,WANG Zhigang,YANG Xia,et al.Gelian Tiaotang Pills Ameliorate Renal Fibrosis in db/db Mice via NLRP3/Caspase-1/GSDMD Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(06):136-145. DOI： 10.13422/j.cnki.syfjx.20241319.

  •  
  •  

0

Views

67

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Research Advances on Anti-inflammatory and Anti-oxidation Effect of Medicinal and Edible Herbs Liver-protecting Chinese Medicine
Yishen Tongluo Prescription Ameliorates Oxidative Stress Injury in Mouse Model of Diabetic Kidney Disease via Nrf2/HO-1/NQO1 Signaling Pathway
Mechanism of Modified Shaofu Zhuyutang in Antagonising Ectopic Endometrial Tissue Fibrosis Based on Cellular Pyroptosis Mediated by TRL4/NF-κB/NLPR3 Signaling Pathway
Traditional Chinese Medicine Treats Diabetic Nephropathy via Pathways Related to Pyroptosis： A Review

Related Author

ZHAO Jinghan
ZHU Zhengwang
WANG Linlin
ZHU Pingsheng
MIAO Mingsan
ZHANG Yifei
BAI Xuehui
CAO Zijing

Related Institution

The First Clinical Medical College of Henan University of Chinese Medicine
School of Pharmacy，Henan University of Chinese Medicine
Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-Yao
Dongzhimen Hospital，Beijing University of Chinese Medicine
Key Laboratory of Chinese Internal Medicine of Ministry of Education，Beijing University of Chinese Medicine
0